Krish S Krishnan Krystal Biotech, Inc. (KRYS) insider trading activity

Krish S Krishnan is President and CEO of Krystal Biotech, Inc.. Currently has a direct ownership of 1.51 Million shares of KRYS, which is worth approximately $226 Million. The most recent transaction as insider was on Jul 16, 2025, when has been sold 1,389 shares (Common Stock) at a price of $150.0 per share, resulting in proceeds of $208,350. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.51M

1.63% 3M change

4.99% 12M change

Total Value Held $226 Million

Krish S Krishnan Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 16 2025	SELL Open market or private sale	$208,350 $150.0 p/Share	1,389 Reduced 0.09%	1,508,056 Common Stock
Jul 15 2025	SELL Open market or private sale	$466,393 $151.23 p/Share	3,084 Reduced 0.2%	1,509,445 Common Stock
Jul 14 2025	SELL Open market or private sale	$2,014,020 $150.3 p/Share	13,400 Reduced 0.88%	1,512,529 Common Stock
Jul 10 2025	SELL Open market or private sale	$1,044,660 $150.81 p/Share	6,927 Reduced 0.45%	1,525,929 Common Stock
Jul 09 2025	SELL Open market or private sale	$30,014 $150.07 p/Share	200 Reduced 0.01%	1,532,856 Common Stock
Mar 13 2025	SELL Open market or private sale	$4,443,000 $177.72 p/Share	25,000 Reduced 1.6%	1,533,056 Common Stock
Feb 28 2025	SELL Payment of exercise price or tax liability	$3,940,811 $179.25 p/Share	21,985 Reduced 1.39%	1,558,056 Common Stock
Feb 28 2025	BUY Exercise of conversion of derivative security	-	47,500 Added 2.94%	1,570,205 Common Stock
Feb 26 2025	SELL Payment of exercise price or tax liability	$832,737 $176.39 p/Share	4,721 Reduced 0.31%	1,532,541 Common Stock
Dec 13 2024	SELL Open market or private sale	$4,176,250 $167.05 p/Share	25,000 Reduced 1.6%	1,537,262 Common Stock
Sep 12 2024	SELL Open market or private sale	$4,962,000 $198.48 p/Share	25,000 Reduced 1.58%	1,562,262 Common Stock
Jun 11 2024	SELL Open market or private sale	$4,376,500 $175.06 p/Share	25,000 Reduced 1.55%	1,587,262 Common Stock
Mar 11 2024	SELL Open market or private sale	$4,276,000 $171.04 p/Share	25,000 Reduced 1.53%	1,612,262 Common Stock
Feb 28 2024	SELL Payment of exercise price or tax liability	$943,417 $163.08 p/Share	5,785 Reduced 0.35%	1,637,262 Common Stock
Feb 28 2024	BUY Exercise of conversion of derivative security	-	12,500 Added 0.76%	1,643,047 Common Stock
Feb 26 2024	SELL Payment of exercise price or tax liability	$595,187 $157.0 p/Share	3,791 Reduced 0.23%	1,630,547 Common Stock
Dec 11 2023	SELL Open market or private sale	$2,648,000 $105.92 p/Share	25,000 Reduced 1.51%	1,634,338 Common Stock
Sep 11 2023	SELL Open market or private sale	$3,180,250 $127.21 p/Share	25,000 Reduced 1.48%	1,659,338 Common Stock
May 31 2023	SELL Open market or private sale	$2,921,250 $116.85 p/Share	25,000 Reduced 1.46%	1,684,338 Common Stock
Apr 17 2023	SELL Open market or private sale	$2,186,500 $87.46 p/Share	25,000 Reduced 1.44%	1,709,338 Common Stock
Feb 26 2023	SELL Payment of exercise price or tax liability	$341,301 $78.46 p/Share	4,350 Reduced 0.25%	1,734,338 Common Stock
Jan 18 2023	SELL Open market or private sale	$231,358 $81.15 p/Share	2,851 Reduced 0.16%	1,738,688 Common Stock
Jan 17 2023	SELL Open market or private sale	$1,807,579 $81.61 p/Share	22,149 Reduced 1.26%	1,741,539 Common Stock
Jan 04 2023	SELL Open market or private sale	$300,139 $80.08 p/Share	3,748 Reduced 0.21%	1,763,688 Common Stock
Jan 03 2023	SELL Open market or private sale	$136,561 $80.33 p/Share	1,700 Reduced 0.1%	1,767,436 Common Stock

KSK

Krish S Krishnan

President and CEO

Pittsburgh, PA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KRYS shares.

Notify only if

Value

Insider Trading

Get notified when an Krystal Biotech, Inc. insider buys or sells KRYS shares.

Notify only if

Operation

Value

Type

News

Receive news related to Krystal Biotech, Inc.

Track Activities on KRYS

Account